-
1دورية أكاديمية
المؤلفون: Sajan C. Raju, Heli Viljakainen, Rejane A. O. Figueiredo, Pertti J. Neuvonen, Johan G. Eriksson, Elisabete Weiderpass, Trine B. Rounge
المصدر: Microbiome, Vol 8, Iss 1, Pp 1-13 (2020)
مصطلحات موضوعية: Lifelong antimicrobial use, Saliva microbiota, Azithromycin, Gender difference, Antibiotics, Microbial ecology, QR100-130
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Tuija Tapaninen, Aleksi M. Olkkola, Aleksi Tornio, Mikko Neuvonen, Erkki Elonen, Pertti J. Neuvonen, Mikko Niemi, Janne T. Backman
المصدر: Clinical and Translational Science, Vol 13, Iss 2, Pp 345-351 (2020)
مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950, Public aspects of medicine, RA1-1270
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Juha Puustinen, Ritva Lähteenmäki, Janne Nurminen, Tero Vahlberg, Pertti Aarnio, Markku Partinen, Ismo Räihä, Pertti J. Neuvonen, Sirkka-Liisa Kivelä
المصدر: BMC Geriatrics, Vol 18, Iss 1, Pp 1-9 (2018)
مصطلحات موضوعية: Benzodiazepine agonists, Long-term hypnotic use, Withdrawal persistence, Follow-up study, Older outpatients, Geriatrics, RC952-954.6
وصف الملف: electronic resource
-
4
المؤلفون: Pertti J. Neuvonen, Uwe Fuhr, Thorsten Lehr, Teijo I. Saari, Chih-hsuan Hsin, Daniel Moj, Klaus T. Olkkola, Max Taubert, Sebastian Frechen, Gerd Mikus, Xia Li
المساهمون: Medicum, Department of Clinical Pharmacology, University of Helsinki, HUS Helsinki and Uusimaa Hospital District, HUS Perioperative, Intensive Care and Pain Medicine, Department of Diagnostics and Therapeutics, Anestesiologian yksikkö
مصطلحات موضوعية: 0301 basic medicine, Physiologically based pharmacokinetic modelling, BIOAVAILABILITY, 030106 microbiology, Cmax, Antifungal drug, CYP2C19, METABOLISM, Pharmacology, GUIDELINES, 030226 pharmacology & pharmacy, 03 medical and health sciences, 0302 clinical medicine, Therapeutic index, Pharmacokinetics, STEADY-STATE PHARMACOKINETICS, HUMAN LIVER, Cytochrome P-450 CYP3A, Humans, Medicine, Drug Interactions, Pharmacology (medical), Voriconazole, SPECTRUM, Polymorphism, Genetic, Maintenance dose, business.industry, GENOTYPE, 3. Good health, Cytochrome P-450 CYP2C19, ANTIFUNGAL AGENT, 317 Pharmacy, SAFETY, SHORT-TERM, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09f3dfcfa12953670807dfc9351bb3e3
-
5
المؤلفون: Janne T. Backman, Tuija Tapaninen, Erkki Elonen, Aleksi M. Olkkola, Pertti J. Neuvonen, Mikko Niemi, Aleksi Tornio, Mikko Neuvonen
المساهمون: HUSLAB, Department of Clinical Pharmacology, University of Helsinki, INDIVIDRUG - Individualized Drug Therapy, Research Programs Unit, Faculty of Medicine, HUS Comprehensive Cancer Center, Hematologian yksikkö, Department of Oncology, Medicum, Janne Backman / Principal Investigator
المصدر: Clinical and Translational Science, Vol 13, Iss 2, Pp 345-351 (2020)
Clinical and Translational Scienceمصطلحات موضوعية: Male, 030213 general clinical medicine, CYP3A4, Administration, Oral, Pharmacology, 030226 pharmacology & pharmacy, PROPHYLAXIS, chemistry.chemical_compound, 0302 clinical medicine, Piperidines, Agammaglobulinaemia Tyrosine Kinase, Medicine, Cytochrome P-450 CYP3A, Drug Interactions, General Pharmacology, Toxicology and Pharmaceutics, Cross-Over Studies, General Neuroscience, lcsh:Public aspects of medicine, General Medicine, Articles, Healthy Volunteers, 3. Good health, itraconazole, 317 Pharmacy, Ibrutinib, Area Under Curve, TYROSINE KINASE INHIBITOR, medicine.drug, Adult, Itraconazole, Cmax, Biological Availability, Placebo, General Biochemistry, Genetics and Molecular Biology, Article, 03 medical and health sciences, Young Adult, Pharmacokinetics, ibrutinib, pharmacokinetic booster, Humans, Dosing, business.industry, Research, Adenine, lcsh:RM1-950, lcsh:RA1-1270, Crossover study, Bioavailability, lcsh:Therapeutics. Pharmacology, chemistry, Biological Variation, Population, Cytochrome P-450 CYP3A Inhibitors, 3111 Biomedicine, business, drug-drug interaction
-
6
المؤلفون: Pertti J. Neuvonen, Trine B. Rounge, Rejane Augusta de Oliveira Figueiredo, Heli Viljakainen, Elisabete Weiderpass, Eero Kajantie
المساهمون: Medicum, Helsinki Institute of Urban and Regional Studies (Urbaria), Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, HUS Children and Adolescents, Lastentautien yksikkö, Clinicum, Children's Hospital, Helsinki University Hospital Area, Department of Clinical Pharmacology, Department of Food and Nutrition
المصدر: Pediatric Obesity
مصطلحات موضوعية: 0301 basic medicine, Male, Pediatric Obesity, register study, CHILDREN, Overweight, Body Mass Index, Cohort Studies, 0302 clinical medicine, Anti-Infective Agents, Prevalence, Registries, adolescents, Child, Finland, Multinomial logistic regression, Original Research, 2. Zero hunger, Nutrition and Dietetics, ANTIBIOTIC USE, Health Policy, GUT MICROBIOTA, 3. Good health, Cohort, INFANCY, Female, medicine.symptom, 3143 Nutrition, Cohort study, 030209 endocrinology & metabolism, antimicrobials, 03 medical and health sciences, Thinness, medicine, Humans, EXPOSURE, 030109 nutrition & dietetics, OVERWEIGHT, business.industry, Public Health, Environmental and Occupational Health, Odds ratio, medicine.disease, Obesity, Confidence interval, weight status, BODY-MASS INDEX, 3121 General medicine, internal medicine and other clinical medicine, Pediatrics, Perinatology and Child Health, business, Body mass index, RESISTANCE, Demography
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3612063e5689932f4a70c608e7dd504
http://hdl.handle.net/10138/326275 -
7
المؤلفون: Matti K. Itkonen, Mikko Niemi, Mikko Neuvonen, Janne T. Backman, Pertti J. Neuvonen, Aleksi Tornio
المساهمون: HUSLAB, Department of Clinical Pharmacology, Medicum, University of Helsinki, Clinicum, Janne Backman / Principal Investigator
المصدر: Drug Metabolism and Disposition. 47:377-385
مصطلحات موضوعية: Adult, Male, CYP2C8, PHARMACOKINETICS, PLASMA-CONCENTRATIONS, Genotype, TRANSPORTING POLYPEPTIDE 1B1, Glucuronidation, Cmax, Pharmaceutical Science, MARKEDLY INCREASES, METABOLISM, Pharmacology, 030226 pharmacology & pharmacy, UGT2B10 GENOTYPE, Cytochrome P-450 CYP2C8, Young Adult, 03 medical and health sciences, Glucuronides, 0302 clinical medicine, Pharmacokinetics, medicine, Humans, Gemfibrozil, Drug Interactions, Biotransformation, Hypolipidemic Agents, GLUCURONIDATION, DRUG-DRUG INTERACTION, Desloratadine, Cross-Over Studies, Chemistry, Loratadine, Clopidogrel, Crossover study, 3. Good health, Cytochrome P-450 CYP2C8 Inhibitors, 317 Pharmacy, Area Under Curve, 030220 oncology & carcinogenesis, Female, Aryl Hydrocarbon Hydroxylases, 3111 Biomedicine, DEPENDENT INHIBITOR, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d3feef04e577c0368de75157b976c99
https://doi.org/10.1124/dmd.118.084665 -
8
المؤلفون: Jouko Laitila, Teijo I. Saari, Kari Laine, Tuija Hemmilä, Mari Fihlman, Klaus T. Olkkola, Nora Hagelberg, Janne T. Backman, Pertti J. Neuvonen
المساهمون: Department of Clinical Pharmacology, Janne Backman / Principal Investigator, Medicum, University of Helsinki, Department of Diagnostics and Therapeutics, Anestesiologian yksikkö, Clinicum, HUS Perioperative, Intensive Care and Pain Medicine, HUSLAB
المصدر: European Journal of Clinical Pharmacology. 74:1615-1622
مصطلحات موضوعية: Male, Antifungal Agents, CYP3A4, HUMAN LIVER-MICROSOMES, Pharmacology, 030226 pharmacology & pharmacy, chemistry.chemical_compound, 0302 clinical medicine, Cytochrome P-450 CYP3A, Medicine, Drug Interactions, Pharmacology (medical), Norbuprenorphine, Biotransformation, SUBLINGUAL BUPRENORPHINE, Cross-Over Studies, OPIOID DEPENDENCE, P-GLYCOPROTEIN, General Medicine, Healthy Volunteers, SYSTEMIC ANTIMYCOTICS, Buprenorphine, 3. Good health, Analgesics, Opioid, IN-VITRO METABOLISM, Transporters, CYTOCHROME-P450 3A4, 317 Pharmacy, Area Under Curve, Female, CLINICAL PHARMACOKINETICS, Half-Life, Drug-drug interaction, medicine.drug, Adult, MAINTENANCE THERAPY, Adolescent, Cmax, Placebo, Dizziness, Sublingual administration, Young Adult, 03 medical and health sciences, Pharmacokinetics, Humans, Voriconazole, business.industry, Drug interaction, N-DEALKYLATION, chemistry, 3111 Biomedicine, business, 030217 neurology & neurosurgery
-
9
المؤلفون: Janne T. Backman, Mikko T. Holmberg, Pertti J. Neuvonen, Mikko Niemi, Mikko Neuvonen, Aleksi Tornio, Maria Paile-Hyvärinen, E. Katriina Tarkiainen
المصدر: Clinical Pharmacology & Therapeutics. 105:448-457
مصطلحات موضوعية: Adult, Male, Ticagrelor, Prasugrel, Genotype, Platelet Aggregation, Platelet Function Tests, CYP3A, CYP2C19, Pharmacology, 030226 pharmacology & pharmacy, Activation, Metabolic, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, Cytochrome P-450 CYP3A, Humans, Medicine, Pharmacology (medical), CYP3A4, business.industry, Genetic Variation, Clopidogrel, Healthy Volunteers, 3. Good health, Area Under Curve, 030220 oncology & carcinogenesis, Pharmacodynamics, Female, business, Prasugrel Hydrochloride, Platelet Aggregation Inhibitors, medicine.drug
-
10
المؤلفون: Mikko Niemi, Mikko Neuvonen, Pertti J. Neuvonen, Matti K. Itkonen, Outi Lapatto-Reiniluoto, Aleksi Tornio, Janne T. Backman
المساهمون: HUSLAB, Department of Clinical Pharmacology, University of Helsinki, Clinicum, Medicum, Janne Backman / Principal Investigator
المصدر: Clinical Pharmacology and Therapeutics
مصطلحات موضوعية: Male, PHARMACOKINETICS, Pharmacology, 030226 pharmacology & pharmacy, chemistry.chemical_compound, 0302 clinical medicine, immune system diseases, 2-Naphthylamine, heterocyclic compounds, Pharmacology (medical), Sulfonamides, Cross-Over Studies, Dasabuvir, virus diseases, Drug Synergism, Articles, Clopidogrel, 3. Good health, PARITAPREVIR/RITONAVIR, 317 Pharmacy, 030220 oncology & carcinogenesis, Drug Therapy, Combination, Female, circulatory and respiratory physiology, medicine.drug, Adult, PLASMA-CONCENTRATIONS, MARKEDLY INCREASES, Article, Young Adult, 03 medical and health sciences, Pharmacokinetics, medicine, Humans, cardiovascular diseases, Uracil, CYP2C8, DRUG-DRUG INTERACTION, CYTOCHROME-P450 3A, Ritonavir, business.industry, Research, OMBITASVIR, PHARMACODYNAMICS, Crossover study, Ombitasvir, PLUS DASABUVIR, ACTING ANTIVIRAL REGIMEN, chemistry, Pharmacodynamics, Cytochrome P-450 CYP3A Inhibitors, 3111 Biomedicine, business, Platelet Aggregation Inhibitors